Pazopanib | FDA Orange Book | Approved Drug Product List | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Pazopanib
FDA Orange Book

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Pazopanib

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

38 API Suppliers, 13 USDMF, 6 EU WC, 5 KDMF, 9 NDC API, 34 Listed Suppliers, $ API Reference Price

38 API Suppliers
13 USDMF
6 EU WC
5 KDMF
9 NDC API
34 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

35 API Suppliers

35 API Suppliers

FINISHED DOSAGE FORMULATIONS

43 FDF Dossiers, 6 FDA Orange Book, 4 Europe, 2 Canada, 12 Australia, 2 South Africa, 17 Listed Dossiers

43 FDF Dossiers
6 FDA Orange Book
4 Europe
2 Canada
12 Australia
2 South Africa
17 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 200MG BASE, TABLET;ORAL - EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 200MG BASE
TABLET;ORAL - EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 3 DKSH, 1 Jai Radhe Sales, 1 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 2 Actylis, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 BASF, 1 Clariant, 10 Corel Pharma Chem, 3 DFE Pharma, 9 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 15 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 9 Microlex e.U, 1 Nanjing Bold Chemical, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 2 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 11 Roquette, 12 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

45 Coating Systems & Additives, 32 Fillers, Diluents & Binders, 23 Controlled & Modified Release, 21 Direct Compression, 18 Solubilizers, 17 Disintegrants & Superdisintegrants, 16 Thickeners and Stabilizers, 13 Granulation, 11 Lubricants & Glidants, 11 Film Formers & Plasticizers, 10 Co-Processed Excipients, 8 Parenteral, 5 Coloring Agents, 5 Emulsifying Agents, 5 Topical, 5 Empty Capsules, 4 Taste Masking, 4 Rheology Modifiers, 4 Vegetarian Capsules, 4 API Stability Enhancers, 3 Chewable & Orodispersible Aids, 3 Surfactant & Foaming Agents

45 Coating Systems & Additives
32 Fillers, Diluents & Binders
23 Controlled & Modified Release
21 Direct Compression
18 Solubilizers
17 Disintegrants & Superdisintegrants
16 Thickeners and Stabilizers
13 Granulation
11 Lubricants & Glidants
11 Film Formers & Plasticizers
10 Co-Processed Excipients
8 Parenteral
5 Coloring Agents
5 Emulsifying Agents
5 Topical
5 Empty Capsules
4 Taste Masking
4 Rheology Modifiers
4 Vegetarian Capsules
4 API Stability Enhancers
3 Chewable & Orodispersible Aids
3 Surfactant & Foaming Agents

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 12 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
12 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 2 Finished Drug Prices, 10 Annual Reports

1 US Medicaid Prescriptions
2 Finished Drug Prices
10 Annual Reports

MARKET PLACE

2 APIs, 6 FDF Dossiers

2 APIs
6 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

2 Health Canada Patents

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 2,849 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

6 All

01 1APOTEX

02 2NOVARTIS

03 1NOVUGEN

04 1SUN PHARM

05 1TEVA PHARMS INC

filter Dosage Reset all filters

6 All

01 6TABLET;ORAL

filter Regulatory Info Reset all filters

6 All

01 1DISCN

02 5RX

filter Brand Name Reset all filters

6 All

01 4PAZOPANIB HYDROCHLORIDE

02 2VOTRIENT

filter RLD Reset all filters

6 All

01 4No

02 2Yes

List of Suppliers

Product Main Page

01

APOTEX

2024 ACI Convention

Not Confirmed

APOTEX

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code : AB

PAZOPANIB HYDROCHLORIDE

Brand Name : PAZOPANIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 200MG BASE

Approval Date : 2023-10-19

Application Number : 217713

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

TEVA PHARMS INC

2024 ACI Convention

Not Confirmed

TEVA PHARMS INC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code : AB

PAZOPANIB HYDROCHLORIDE

Brand Name : PAZOPANIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 200MG BASE

Approval Date : 2023-10-19

Application Number : 217517

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

NOVARTIS

2024 ACI Convention

Not Confirmed

NOVARTIS

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code : AB

PAZOPANIB HYDROCHLORIDE

Brand Name : VOTRIENT

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 200MG BASE

Approval Date : 2009-10-19

Application Number : 22465

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

NOVARTIS

2024 ACI Convention

Not Confirmed

NOVARTIS

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code :

PAZOPANIB HYDROCHLORIDE

Brand Name : VOTRIENT

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 2009-10-19

Application Number : 22465

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

NOVUGEN

2024 ACI Convention

Not Confirmed

NOVUGEN

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code : AB

PAZOPANIB HYDROCHLORIDE

Brand Name : PAZOPANIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 200MG BASE

Approval Date : 2024-04-23

Application Number : 218231

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

SUN PHARM

2024 ACI Convention

Not Confirmed

SUN PHARM

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code : AB

PAZOPANIB HYDROCHLORIDE

Brand Name : PAZOPANIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 200MG BASE

Approval Date : 2023-10-19

Application Number : 215837

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?